Endocrinology, Diabetes & Hypertension Research

The mission of the division is to perform outstanding basic and clinical research in endocrine related subjects, to train individuals for future leadership positions in academic endocrinology, and to provide the highest quality of clinical care for patients with endocrinological disorders.

Dr. Ursula B. Kaiser was appointed Chief of the Division of Endocrinology, Diabetes, and Hypertension effective July 1, 2007.

The division occupies clinical, research and faculty office space at 221 Longwood Avenue, as well as research and faculty office space at Harvard Institutes of Medicine. The clinic space underwent an extensive renovation in 2005 and is now a facility approved by the Mass Department of Public Health.

There are 45 faculty members, half of whom are at the Assistant Professor rank and above, as well as numerous clinical and research fellows, nursing and technical professionals, and administrative support staff. Clinical revenues exceed $2 million annually; three quarters is derived from the outpatient practice, and one quarter from the inpatient Diabetes Management Service and from clinical procedures.

Major recruitments over the last five years include Yujiang Shi, Ph.D., who is the recent recipient of a Pew Scholars Award, and Carolyn Becker, M.D., who was recruited to the position of Master Clinician and started in July 2007.

Seventeen physicians, three nurse practitioners, and a nurse care for patients in the outpatient practice, operating from space that is contiguous to the faculty offices and comprised of six exam rooms, specimen collection, and bone densitometry machines. The outpatient practice is also utilized in the training of clinical fellows, medical residents, and medical students. We also have physicians practicing in other locations, including Neurosurgery, 850 Boylston Street, Center for Women and Newborns, and the Shapiro Building.

The Division’s space, totaling 23,000 square feet, consists of 6,000 square feet for the clinic and faculty offices, 12,000 square feet of wet lab space located in an adjacent wing, and an additional 4,000 square feet for laboratory and faculty office space in a nearby building.

Direct cost research expenditures have been $6 million annually, funded by a variety of federal sources, private foundations, and corporate entities. The Division is also the recipient of two NIH training grants, with 11 current trainee slots.

During the past five years, the overall research portfolio of the Division has remained at a relatively stable level, with total direct cost expenditures of $6 million. Seventy-five percent of the Division’s support is from the NIH, with most of the remainder (24%) from non-profit sources, mostly collaborations with other comparable entities.

In many research projects in the Endocrine Division, there is a two-pronged approach with projects encompassing both patient-oriented and bench-oriented research. The members of the Division have extensive collaborations with other divisions and departments of BWH, HMS and the School of Public Health (HSPH)